We are live on
!
Find out more
Mackenzie Financial Portfolio holdings
AUM
$83.3B
1-Year Est. Return
31.19%
This Fund
S&P 500
This Quarter
Est. Return
+5.1%
1 Year Est. Return
+31.19%
3 Year Est. Return
+75.49%
5 Year Est. Return
+99.03%
10 Year Est. Return
+295.58%
AUM
$84.4B
AUM Growth
+$1.88B
(+2.3%)
Cap. Flow
-$1.02B
Cap. Flow
% of AUM
-1.21%
Top 10 Holdings %
Top 10 Hldgs %
26.68%
Holding
1,838
New
139
Increased
801
Reduced
650
Closed
172
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian Imperial Bank of Commerce
CM
|
+$379M |
| 2 |
BGSI
Boyd Group Services
BGSI
|
+$328M |
| 3 |
B
Barrick Mining
B
|
+$295M |
| 4 |
Eli Lilly
LLY
|
+$220M |
| 5 |
Johnson & Johnson
JNJ
|
+$159M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Scotiabank
BNS
|
+$342M |
| 2 |
MRSH
Marsh
MRSH
|
+$266M |
| 3 |
Automatic Data Processing
ADP
|
+$234M |
| 4 |
Microsoft
MSFT
|
+$202M |
| 5 |
Sun Life Financial
SLF
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.65% |
| 2 | Technology | 21.47% |
| 3 | Industrials | 9.42% |
| 4 | Materials | 9.04% |
| 5 | Healthcare | 7.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Fox Class B
FOX
$22.1B
| $1.22M | ﹤0.01% |
18,648
+1,571
| +9% | +$91.7K |
|
1002
FIVE9
FIVN
$2.22B
| $1.21M | ﹤0.01% |
60,553
+24,076
| +66% | +$511K |
|
1003
Affirm
AFRM
$25.3B
| $1.21M | ﹤0.01% |
15,930
-65
| -0.4% | -$4.68K |
|
1004
Zymeworks
ZYME
$1.6B
| $1.2M | ﹤0.01% |
45,460
-10,917
| -19% | -$238K |
|
1005
Pediatrix Medical
MD
$2.16B
| $1.2M | ﹤0.01% |
55,150
+14,502
| +36% | +$297K |
|
1006
Madison Square Garden
MSGE
$3.64B
| $1.2M | ﹤0.01% |
+22,282
| New | +$1.07M |
|
1007
Core Molding Technologies
CMT
$206M
| $1.19M | ﹤0.01% |
58,964
-7,066
| -11% | -$135K |
|
1008
Harmonic Inc
HLIT
$1.28B
| $1.18M | ﹤0.01% |
119,309
+105,514
| +765% | +$1.06M |
|
1009
Rapid7
RPD
$680M
| $1.18M | ﹤0.01% |
75,679
+7,742
| +11% | +$127K |
|
1010
Main Street Capital
MAIN
$5.18B
| $1.17M | ﹤0.01% |
19,518
+145
| +0.7% | +$8.55K |
|
1011
The Ensign Group
ENSG
$10.3B
| $1.17M | ﹤0.01% |
6,646
+3,079
| +86% | +$553K |
|
1012
Mitek Systems
MITK
$767M
| $1.17M | ﹤0.01% |
111,264
+23,355
| +27% | +$221K |
|
1013
AnaptysBio
ANAB
$1.59B
| $1.17M | ﹤0.01% |
+24,228
| New | +$944K |
|
1014
Amer Sports
AS
$21.1B
| $1.17M | ﹤0.01% |
30,945
-17,800
| -37% | -$611K |
|
1015
American Superconductor
AMSC
$1.5B
| $1.16M | ﹤0.01% |
40,245
+5,956
| +17% | +$258K |
|
1016
Teladoc Health
TDOC
$1.21B
| $1.16M | ﹤0.01% |
165,550
+46,090
| +39% | +$361K |
|
1017
Ardelyx
ARDX
$1.23B
| $1.16M | ﹤0.01% |
199,550
+22,715
| +13% | +$127K |
|
1018
BioCryst Pharmaceuticals
BCRX
$2.24B
| $1.15M | ﹤0.01% |
150,728
+21,411
| +17% | +$155K |
|
1019
Guidewire Software
GWRE
$13.1B
| $1.15M | ﹤0.01% |
5,693
+458
| +9% | +$101K |
|
1020
EPAM Systems
EPAM
$5.6B
| $1.14M | ﹤0.01% |
5,538
-35,691
| -87% | -$6.36M |
|
1021
Alaska Air
ALK
$5.6B
| $1.14M | ﹤0.01% |
22,713
-1,252
| -5% | -$57.9K |
|
1022
Impinj
PI
$4.93B
| $1.14M | ﹤0.01% |
6,746
+5,090
| +307% | +$907K |
|
1023
Pitney Bowes
PBI
$2.48B
| $1.13M | ﹤0.01% |
106,661
+95,320
| +840% | +$989K |
|
|
CVSA
1024
Covista Inc
CVSA
$4.34B
| $1.13M | ﹤0.01% |
10,888
+4,780
| +78% | +$547K |
|
1025
Elbit Systems
ESLT
$38.9B
| $1.11M | ﹤0.01% |
1,919
+9
| +0.5% | +$4.51K |
|
Similar funds
Mackenzie Financial's Q4 2025 Portfolio in Review
As of Q4 2025, Mackenzie Financial held 1,838 positions worth $84.4B, up 2.3% from $82.6B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Mackenzie Financial's Q4 2025 filing shows 139 new, 801 increased, 650 reduced and 172 closed positions. Its largest new stake was Boyd Group Services: 2,050,220 shares worth $328M. The largest sale was Scotiabank, an estimated $342M.
By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 21% a quarter earlier, followed by Technology and Industrials.
- Mackenzie Financial's largest Q4 2025 buy was Boyd Group Services: 2,050,220 shares worth $328M.
- Mackenzie Financial added most to Canadian Imperial Bank of Commerce in Q4 2025, an estimated $379M increase.
- Mackenzie Financial's biggest Q4 2025 reduction was Scotiabank, cutting an estimated $342M.
- Mackenzie Financial fully exited Novo Nordisk in Q4 2025, selling an estimated $16.1M.
- Mackenzie Financial's ten largest holdings make up 27% of its $84.4B portfolio in Q4 2025.
- Mackenzie Financial opened 139 new positions and closed 172 in Q4 2025.
- Mackenzie Financial's portfolio value rose 2.3% quarter-over-quarter to $84.4B.
Based on Mackenzie Financial's 13F filing for Q4 2025, filed 18 Feb 2026.